BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Brain cancer AND ERCC2, TTD, 2068, ENSG00000104884, COFS2, P18074, MGC102762, XPD, MGC126219, MGC126218, EM9 AND Diagnosis
11 results:

  • 1. Real-World Treatment Patterns and Clinical Outcomes After Platinum-Doublet Chemotherapy and Immunotherapy in Metastatic Non-Small Cell Lung cancer: A Multiregional Chart Review in the United States, Europe, and Japan.
    Leal TA; Dasgupta A; Latremouille-Viau D; Rossi C; Rai P; Barlesi F; Liu SV
    JCO Glob Oncol; 2024 Mar; 10():e2300483. PubMed ID: 38484195
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Clinical presentation of childhood soft tissue sarcomas: a systematic review and meta-analysis.
    Ni Cheallaigh L; Liu JF; Fern L; Winyard P; Walker D; Ball-Gamble A; Shanmugavadivel D
    Arch Dis Child; 2024 Jan; 109(2):113-120. PubMed ID: 37857451
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. The XRCC1 and TP53 gene polymorphisms are associated with advanced-stage disease and early distant metastasis at diagnosis in non-small cell lung cancer.
    Karaağaç M; Geredeli Ç; Yıldırım MS; Altınok T; Dede İ; İnal A; Zamani AG; Kaya B; Demirkazık A; Artaç M
    J Cancer Res Ther; 2023; 19(5):1248-1254. PubMed ID: 37787291
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Real-World Evaluation of the Management, Treatment Pathways and Outcome of Melanoma Patients with Target Therapies in Italy.
    Marcon IG; Valsecchi D; Durso L; Premoli E; Sangiorgi D; Perrone V; Catena L; Degli Esposti L
    Adv Ther; 2023 Sep; 40(9):3875-3895. PubMed ID: 37368101
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. First-Line Osimertinib in Patients with EGFR-Mutant Advanced Non-Small Cell Lung cancer: Outcome and Safety in the Real World: FLOWER Study.
    Lorenzi M; Ferro A; Cecere F; Scattolin D; Del Conte A; Follador A; Pilotto S; Polo V; Santarpia M; Chiari R; Pavan A; Dal Maso A; Da Ros V; Targato G; Vari S; Indraccolo S; Calabrese F; Frega S; Bonanno L; Conte PF; Guarneri V; Pasello G
    Oncologist; 2022 Mar; 27(2):87-e115. PubMed ID: 35641222
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Impact of Time to diagnosis on Morbidity and Survival in Children With Malignant Central Nervous System Tumors.
    Ronsley R; Crowell C; Irvine M; Kang M; Goldman RD; Erker C; Cheng S
    J Pediatr Hematol Oncol; 2023 Mar; 45(2):e188-e193. PubMed ID: 35129148
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Stimulated Raman Histology for Rapid Intraoperative diagnosis of Gliomas.
    Di L; Eichberg DG; Huang K; Shah AH; Jamshidi AM; Luther EM; Lu VM; Komotar RJ; Ivan ME; Gultekin SH
    World Neurosurg; 2021 Jun; 150():e135-e143. PubMed ID: 33684587
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Achieving a timely diagnosis for teenagers and young adults with cancer: the ACE "too young to get cancer?" study.
    Dommett RM; Pring H; Cargill J; Beynon P; Cameron A; Cox R; Nechowska A; Wint A; Stevens MCG
    BMC Cancer; 2019 Jun; 19(1):616. PubMed ID: 31234813
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Exploratory analysis of ercc2 DNA methylation in survival among pediatric medulloblastoma patients.
    Banfield E; Brown AL; Peckham EC; Rednam SP; Murray J; Okcu MF; Mitchell LE; Chintagumpala MM; Lau CC; Scheurer ME; Lupo PJ
    Cancer Epidemiol; 2016 Oct; 44():161-166. PubMed ID: 27607585
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. A systematic review of time to diagnosis in children and young adults with cancer.
    Lethaby CD; Picton S; Kinsey SE; Phillips R; van Laar M; Feltbower RG
    Arch Dis Child; 2013 May; 98(5):349-55. PubMed ID: 23476000
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Genomic copy number changes of DNA repair genes ERCC1 and ercc2 in human gliomas.
    Liang BC; Ross DA; Reed E
    J Neurooncol; 1995 Oct; 26(1):17-23. PubMed ID: 8583241
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.